AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Cefixime in South Africa
4 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CEFIXIME 400 TABLETS RESMED | 53/20.1.1/0172 | Resmed Healthcare | active | 11 Jul 2028 |
| FIXIME PAEDIATRIC 100 mg/5 ml* | W/20.1.1/257 | Merck (Pty) Ltd | suspended | 7 Mar 2022 |
| FIXIME 200 mg | W/20.1.1/255 | Merck (Pty) Ltd | suspended | 7 Mar 2022 |
| FIXIME 400 mg* | W/20.1.1/256 | Merck (Pty) Ltd | active | 1 Jan 1900 |
Cefixime — SAHPRA Registration Details
SAHPRA (South Africa) has 4 registered products containing Cefixime, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Cefixime registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.